Literature DB >> 2625207

Quantitative assessment of aqueous flare intensity in diabetes.

T Oshika1, S Kato, H Funatsu.   

Abstract

Aqueous flare intensity was measured with the laser flare-cell meter in 231 eyes of diabetic patients and 31 eyes of normal age-matched controls. Diabetic patients were divided into four groups based on the degree of retinopathy: (1) non-retinopathy, 42 eyes; (2) background retinopathy, 72; (3) preproliferative retinopathy, 23; and (4) proliferative retinopathy, 94. There was no significant difference between the normal controls and the non-retinopathy group, whereas the rest of the diabetic groups showed significantly higher flare values than did normal controls (P less than 0.001). Flare intensity increased with the progression of retinopathy. Our results demonstrate that clinical use of the flare-cell meter enables the quantitative assessment of blood-aqueous barrier function in diabetics and suggest that diabetic iridopathy, as one of the manifestations of diabetes in the anterior part of the eye, exists even in the early stages of this disease and progresses in parallel with retinopathy.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2625207     DOI: 10.1007/bf02169443

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  31 in total

1.  Diurnal variation of aqueous flare in normal human eyes measured with laser flare-cell meter.

Authors:  T Oshika; M Araie; K Masuda
Journal:  Jpn J Ophthalmol       Date:  1988       Impact factor: 2.447

2.  [Permeability of the blood-ocular barrier in diabetics without retinopathy].

Authors:  A Yoshida; M Kojima; Y Nara; I Ohta
Journal:  Nippon Ganka Gakkai Zasshi       Date:  1988-06

3.  Study of fluorescein glucuronide. II. A comparative ocular kinetic study of fluorescein and fluorescein glucuronide.

Authors:  C Seto; M Araie; M Takase
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1986       Impact factor: 3.117

4.  The proteins of the aqueous humour.

Authors:  J P Dernouchamps
Journal:  Doc Ophthalmol       Date:  1982-11-01       Impact factor: 2.379

5.  New quantitative method to determine protein concentration and cell number in aqueous in vivo.

Authors:  M Sawa; Y Tsurimaki; T Tsuru; H Shimizu
Journal:  Jpn J Ophthalmol       Date:  1988       Impact factor: 2.447

6.  Plasma binding of fluorescein in normal subjects and in diabetic patients.

Authors:  A G Palestine; R F Brubaker
Journal:  Arch Ophthalmol       Date:  1982-07

7.  The effect of timolol on the concentrations of albumin and IgG in the aqueous humor of the human eye.

Authors:  M Stur; G Grabner; W Dorda; G Zehetbauer
Journal:  Am J Ophthalmol       Date:  1983-12       Impact factor: 5.258

8.  Metabolism of fluorescein after intravenous administration.

Authors:  P S Chahal; M J Neal; E M Kohner
Journal:  Invest Ophthalmol Vis Sci       Date:  1985-05       Impact factor: 4.799

9.  Effect of timolol on aqueous humor protein concentration in humans.

Authors:  T L Beardsley; M B Shields
Journal:  Am J Ophthalmol       Date:  1983-04       Impact factor: 5.258

10.  Uveitis and diabetes mellitus.

Authors:  A Rothova; C Meenken; R P Michels; A Kijlstra
Journal:  Am J Ophthalmol       Date:  1988-07-15       Impact factor: 5.258

View more
  15 in total

1.  Evaluation of the blood-aqueous barrier by laser flare cell photometry following retinal cryocoagulation.

Authors:  Nicole Eter; Manfred Spitznas; Zaher Sbeity; Antje Vogel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-12-05       Impact factor: 3.117

2.  Continued breakdown of the blood aqueous barrier following cataract surgery.

Authors:  V M Ferguson; D J Spalton
Journal:  Br J Ophthalmol       Date:  1992-08       Impact factor: 4.638

3.  Aqueous flare in eyes with senile disciform macular degeneration: correlation with clinical stage and area of neovascular membrane.

Authors:  T Kubota; K Motomatsu; M Sakamoto; T Honda; T Ishibashi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-05       Impact factor: 3.117

4.  Laser flare intensity in diabetics.

Authors:  A P Moriarty; D J Spalton
Journal:  Br J Ophthalmol       Date:  1995-03       Impact factor: 4.638

5.  Anterior capsular contraction after cataract surgery in eyes of diabetic patients.

Authors:  S Kato; T Oshika; J Numaga; Y Hayashi; M Oshiro; T Yuguchi; T Kaiya
Journal:  Br J Ophthalmol       Date:  2001-01       Impact factor: 4.638

6.  A prospective evaluation of posterior capsule opacification in eyes with diabetes mellitus: a case-control study.

Authors:  M R Praveen; A R Vasavada; G D Shah; A R Shah; B M Khamar; K H Dave
Journal:  Eye (Lond)       Date:  2014-03-28       Impact factor: 3.775

7.  Diabetic cataract-pathogenesis, epidemiology and treatment.

Authors:  Andreas Pollreisz; Ursula Schmidt-Erfurth
Journal:  J Ophthalmol       Date:  2010-06-17       Impact factor: 1.909

8.  Aqueous flare and cells in eyes with retinal vein occlusion--correlation with retinal fluorescein angiographic findings.

Authors:  N X Nguyen; M Küchle
Journal:  Br J Ophthalmol       Date:  1993-05       Impact factor: 4.638

9.  Laser flare intensity in diabetics: correlation with retinopathy and aqueous protein concentration.

Authors:  M Ino-ue; A Azumi; H Shirabe; Y Tsukahara; M Yamamoto
Journal:  Br J Ophthalmol       Date:  1994-09       Impact factor: 4.638

10.  A laboratory evaluation of the Kowa laser flare-cell meter for the study of uveitis.

Authors:  M Ni; J N Bloom; S Lele; C Sotelo-Avila
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.